CEO: Glaxo is diversifying, fostering research for cheap new drugs for poor countries
KFSM - 3 hours ago
NEW YORK (AP) — Andrew Witty, who took over as GlaxoSmithKline PLC's chief executive in May 2008, has been remaking the company from a pure pharmaceutical business to a diverse healthcare ...
http://digg.com/u1MAyl
No comments:
Post a Comment